CDNA Q2 2020 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$858M

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$42M+32.9% YoY

Gross Profit

$27M64.1% margin

Operating Income

-$11M-25.8% margin

Net Income

-$7M-15.7% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+8.9%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$20M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$345M

Total Liabilities

$84M

Stockholders' Equity

$261M

Cash & Equivalents

$211M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$31M	+32.9%
Gross Profit	$27M	$20M	+34.3%
Operating Income	-$11M	-$7M	-57.8%
Net Income	-$7M	-$8M	+16.4%

Geographic Segments

UNITED STATES

$36M96%

Europe

$1M4%

Rest Of The World

$85,0000%